Style | Citing Format |
---|---|
MLA | Motahari R, et al.. "Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents." Scientific Reports, vol. 12, no. 1, 2022, pp. -. |
APA | Motahari R, Boshagh MA, Moghimi S, Peytam F, Hasanvand Z, Oghabi Bakhshaiesh T, Foroumadi R, Bijanzadeh H, Firoozpour L, Khalaj A, Esmaeili R, Foroumadi A (2022). Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents. Scientific Reports, 12(1), -. |
Chicago | Motahari R, Boshagh MA, Moghimi S, Peytam F, Hasanvand Z, Oghabi Bakhshaiesh T, Foroumadi R, et al.. "Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents." Scientific Reports 12, no. 1 (2022): -. |
Harvard | Motahari R et al. (2022) 'Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents', Scientific Reports, 12(1), pp. -. |
Vancouver | Motahari R, Boshagh MA, Moghimi S, Peytam F, Hasanvand Z, Oghabi Bakhshaiesh T, et al.. Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents. Scientific Reports. 2022;12(1):-. |
BibTex | @article{ author = {Motahari R and Boshagh MA and Moghimi S and Peytam F and Hasanvand Z and Oghabi Bakhshaiesh T and Foroumadi R and Bijanzadeh H and Firoozpour L and Khalaj A and Esmaeili R and Foroumadi A}, title = {Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents}, journal = {Scientific Reports}, volume = {12}, number = {1}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Motahari R AU - Boshagh MA AU - Moghimi S AU - Peytam F AU - Hasanvand Z AU - Oghabi Bakhshaiesh T AU - Foroumadi R AU - Bijanzadeh H AU - Firoozpour L AU - Khalaj A AU - Esmaeili R AU - Foroumadi A TI - Design, Synthesis and Evaluation of Novel Tetrahydropyridothienopyrimidin-Ureas As Cytotoxic and Anti-Angiogenic Agents JO - Scientific Reports VL - 12 IS - 1 SP - EP - PY - 2022 ER - |